Breaking News Instant updates and real-time market news.

CARA

Cara Therapeutics

$7.56

-0.6 (-7.35%)

07:08
10/13/16
10/13
07:08
10/13/16
07:08

Cara Therapeutics initiated with a Buy at H.C. Wainwright

H.C. Wainwright analyst Corey Davis started Cara Therapeutics with a Buy rating and $20 price target. The company's CR845 presents an opportunity treat peripheral pain without addiction potential, the analyst contends.

  • 29

    Nov

CARA Cara Therapeutics
$7.56

-0.6 (-7.35%)

11/04/15
JANY
11/04/15
INITIATION
Target $28
JANY
Buy
Cara Therapeutics resumed with a Buy at Janney Capital
Target $28.
11/04/15
11/04/15
INITIATION

On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Allegiance Bancshares (ABTX) initiated with a Market Perform at Keefe Bruyette... BioDelivery Sciences (BDSI) initiated with a Buy at Cantor... Cabela's (CAB) initiated with an Overweight at Barclays... Cara Therapeutics (CARA) initiated with a Buy at Cantor... Chembio Diagnostics (CEMI) initiated with a Speculative Buy at Benchmark... Depomed (DEPO) initiated with a Buy at Cantor... Dick's Sporting (DKS) initiated with an Equal Weight at Barclays... Egalet (EGLT) initiated with a Buy at Cantor... Flexion (FLXN) initiated with a Buy at Cantor... HP Enterprise (HPE) initiated with a Buy at UBS... HP Inc. (HPQ) initiated with a Neutral at UBS... Opexa Therapeutics (OPXA) initiated with a Buy at Chardan... Smith & Nephew (SNN) initiated with a Neutral at Sterne Agee CRT... Stryker (SYK) initiated with a Neutral at Sterne Agee CRT... The Medicines Co. (MDCO) initiated with a Buy at Chardan... Tonix Pharmaceuticals (TNXP) initiated with a Buy at Cantor... Vail Resorts (MTN) initiated with a Buy at Janney Capital... Wright Medical (WMGI) initiated with a Buy at Sterne Agee CRT... Zimmer Biomet (ZBH) initiated with a Buy at Sterne Agee CRT.
12/31/15
PIPR
12/31/15
NO CHANGE
Target $34
PIPR
Overweight
Cara Therapeutics called a top 2016 pick at Piper Jaffray
Piper Jaffray analyst Charles Duncan highlights Cara Therapeutics (CARA) as his top pick going into 2016. The analyst likens the company's position to Neurocrine's (NBIX) last year, which he points out gained 150% at the end of 2014 to present. Cara has "notable value creation" potential from two Phase III read-outs of candidates with a "well-vetted mechanism of action in large-market indications," Duncan tells investors in a New Year's Eve research note. The analyst expects Cara's peak sales to reach four times its current market capitalization. He recommends buying the stock ahead of the Phase III readouts and keeps an Overweight rating on the stock with a $34 price target. Duncan expects the company to begin a pivotal trial of IV'845 in uremic pruritus in early 2016, with data being announced likely in Q4. Cara closed yesterday down 33c to $15.79 with a market cap of just below $440M.
02/26/16
CANT
02/26/16
NO CHANGE
CANT
Delay caused by Cara Therapeutics hold will be short, says Cantor
After Cara announced a clinical hold on the Phase III trial of its IV CR845 drug for post-surgical pain, the firm thinks the hold was unnecessary and does not expect it to delay the drug's advancement for more than three months. Cantor keeps a $28 price target and Buy rating on the shares.

TODAY'S FREE FLY STORIES

OMED

OncoMed

$3.77

0.04 (1.07%)

16:48
04/24/17
04/24
16:48
04/24/17
16:48
Hot Stocks
OncoMed announces workforce reduction »

OncoMed Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

ESRX

Express Scripts

$67.25

0.79 (1.19%)

, ANTM

Anthem

$168.41

0.61 (0.36%)

16:46
04/24/17
04/24
16:46
04/24/17
16:46
Hot Stocks
Express Scripts down 12% after contract with Anthem unlikely to be renewed »

In after hours trading,…

ESRX

Express Scripts

$67.25

0.79 (1.19%)

ANTM

Anthem

$168.41

0.61 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 18

    May

  • 06

    Jun

OI

Owens-Illinois

$21.34

0.83 (4.05%)

16:46
04/24/17
04/24
16:46
04/24/17
16:46
Earnings
Owens-Illinois sees FY17 EPS $2.40-$2.50, consensus $2.43 »

The Company continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ESRX

Express Scripts

$67.25

0.79 (1.19%)

16:45
04/24/17
04/24
16:45
04/24/17
16:45
Hot Stocks
Breaking Hot Stocks news story on Express Scripts »

Express Scripts trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 06

    Jun

OI

Owens-Illinois

$21.34

0.83 (4.05%)

16:44
04/24/17
04/24
16:44
04/24/17
16:44
Earnings
Owens-Illinois reports Q1 EPS 58c, consensus 53c »

Reports Q1 revenue $1.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

WFC

Wells Fargo

$53.65

0.65 (1.23%)

16:44
04/24/17
04/24
16:44
04/24/17
16:44
Hot Stocks
Federal Reserve, FDIC approve revised Wells Fargo living will »

The Federal Deposit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 11

    May

  • 31

    May

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

ESRX

Express Scripts

$67.25

0.79 (1.19%)

, ANTM

Anthem

$168.41

0.61 (0.36%)

16:43
04/24/17
04/24
16:43
04/24/17
16:43
Hot Stocks
Express Scripts CEO: 'Perplexed' by potential loss of Anthem contract »

Says Anthem deal is…

ESRX

Express Scripts

$67.25

0.79 (1.19%)

ANTM

Anthem

$168.41

0.61 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 18

    May

  • 06

    Jun

SMMF

Summit Financial Group

$23.00

0.28 (1.23%)

16:41
04/24/17
04/24
16:41
04/24/17
16:41
Hot Stocks
Summit Financial Group announces resolution of litigation »

Summit Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$80.05

0.77 (0.97%)

, ESRX

Express Scripts

$67.25

0.79 (1.19%)

16:39
04/24/17
04/24
16:39
04/24/17
16:39
Hot Stocks
Breaking Hot Stocks news story on CVS Health, Express Scripts, Anthem »

CVS up 2% after Express…

CVS

CVS Health

$80.05

0.77 (0.97%)

ESRX

Express Scripts

$67.25

0.79 (1.19%)

ANTM

Anthem

$168.41

0.61 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 02

    May

  • 10

    May

  • 18

    May

  • 06

    Jun

NVS

Novartis

$74.61

1.21 (1.65%)

16:39
04/24/17
04/24
16:39
04/24/17
16:39
Hot Stocks
Novartis expands pact with Amgen to commercialize AMG 334 for migraine »

Novartis (NVS) announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 06

    Jun

  • 26

    Jun

HMN

Horace Mann

$39.25

0.15 (0.38%)

16:39
04/24/17
04/24
16:39
04/24/17
16:39
Earnings
Horace Mann reports Q1 EPS 37c with items, may not compare to consensus 55c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

WNC

Wabash

$20.36

0.64 (3.25%)

16:36
04/24/17
04/24
16:36
04/24/17
16:36
Earnings
Breaking Earnings news story on Wabash »

Wabash sees FY17 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 23

    May

  • 24

    May

WFC

Wells Fargo

$53.65

0.65 (1.23%)

16:36
04/24/17
04/24
16:36
04/24/17
16:36
Periodicals
Breaking Periodicals news story on Wells Fargo »

Fed clears Wells Fargo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 11

    May

  • 31

    May

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

WNC

Wabash

$20.36

0.64 (3.25%)

16:35
04/24/17
04/24
16:35
04/24/17
16:35
Earnings
Wabash reports Q1 EPS 32c, consensus 27c »

Reports Q1 revenue $363M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 23

    May

  • 24

    May

BCR

C.R. Bard

$302.41

49.34 (19.50%)

, BDX

Becton Dickinson

$177.07

-8.22 (-4.44%)

16:34
04/24/17
04/24
16:34
04/24/17
16:34
General news
On The Fly: Top stock stories for Monday »

Stocks began the session…

BCR

C.R. Bard

$302.41

49.34 (19.50%)

BDX

Becton Dickinson

$177.07

-8.22 (-4.44%)

PPG

PPG

$108.01

2.07 (1.95%)

AKZOY

AkzoNobel

$29.73

1.77 (6.33%)

ARNC

Arconic

$26.10

0.1 (0.38%)

HAS

Hasbro

$101.70

5.67 (5.90%)

SRPT

Sarepta

$34.02

1.41 (4.32%)

W

Wayfair

$43.48

-2.48 (-5.40%)

AMZN

Amazon.com

$907.41

8.88 (0.99%)

HLX

Helix Energy

$6.06

-1.03 (-14.53%)

HAL

Halliburton

$46.75

-0.31 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 26

    Apr

  • 27

    Apr

  • 27

    Apr

  • 01

    May

  • 01

    May

  • 03

    May

  • 04

    May

  • 09

    May

  • 16

    May

  • 17

    May

  • 17

    May

  • 18

    May

  • 23

    May

  • 31

    May

  • 06

    Jun

PII

Polaris Industries

$83.14

1.28 (1.56%)

16:34
04/24/17
04/24
16:34
04/24/17
16:34
Hot Stocks
Polaris Industries discontinuing manufacturing at its plant in Milford, Iowa »

Polaris Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

UIS

Unisys

$11.15

0.2 (1.83%)

16:33
04/24/17
04/24
16:33
04/24/17
16:33
Earnings
Unisys sees FY17 revenue $2.65B-2.75B, consensus $2.71B »

Sees FY17 non-GAAP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 26

    Apr

CVRS

Corindus

16:33
04/24/17
04/24
16:33
04/24/17
16:33
Hot Stocks
Corindus announces strategic partnership with BLOXR »

Corindus Vascular…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

HSTM

HealthStream

$23.62

-0.08 (-0.34%)

16:32
04/24/17
04/24
16:32
04/24/17
16:32
Earnings
HealthStream backs FY17 consolidated revenue growth view of 10%-14% »

Consensus $252.3M. Backs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

UIS

Unisys

$11.15

0.2 (1.83%)

16:32
04/24/17
04/24
16:32
04/24/17
16:32
Earnings
Unisys reports Q1 EPS (65c), consensus (60c) »

Reports Q1 revenue $665M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 26

    Apr

AMGN

Amgen

$163.14

2.73 (1.70%)

, NVS

Novartis

$74.61

1.21 (1.65%)

16:32
04/24/17
04/24
16:32
04/24/17
16:32
Hot Stocks
Amgen announces expanded collarboration with Novartis for erenumab »

Amgen (AMGN) announced an…

AMGN

Amgen

$163.14

2.73 (1.70%)

NVS

Novartis

$74.61

1.21 (1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 06

    Jun

  • 26

    Jun

  • 19

    Jul

  • 14

    Aug

HSTM

HealthStream

$23.62

-0.08 (-0.34%)

16:31
04/24/17
04/24
16:31
04/24/17
16:31
Earnings
HealthStream reports Q1 EPS 4c, consensus 4c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

RE

Everest Re

$239.38

5.65 (2.42%)

16:31
04/24/17
04/24
16:31
04/24/17
16:31
Earnings
Everest Re reports Q1 after-tax operating EPS $6.29, consensus $5.31 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

16:31
04/24/17
04/24
16:31
04/24/17
16:31
Options
Preliminary option volume of 18.1M today »

Preliminary option volume…

CTRV

ContraVir Pharmaceuticals

$1.18

-0.23 (-16.31%)

16:30
04/24/17
04/24
16:30
04/24/17
16:30
Syndicate
ContraVir Pharmaceuticals files to sell common stock and warrants »

ContraVir intends to use…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.